Promise Seen in Drug for Heart Failure
30062
By Reuters. In the first major trial to test a drug only in blacks, an experimental drug developed by NitroMed Inc., combined with standard therapy, helped heart failure patients live significantly longer, researchers said yesterday.
21611
One undervalued drug developer may be on the cusp of greatness.
147168
The approval of a new drug is a long-term opportunity.
505932
NEW ORLEANS -- A fixed-dose combination of two rarely used heart drugs cut death rates among black heart-failure patients almost in half, researchers reported Monday.
377388
A way to measure energy levels inside living heart cells could ultimately aid heart attack recovery.
168198
A drug to treat a common eye disease that damages vision produced promising results in a major trial, researchers say.
573459
A key study of its lead drug proceeds faster than expected.
177905
A new heart drug targeted exclusively at blacks reduced deaths from advanced heart failure by 43 percent and reduced hospitalizations by a third, setting the stage for it to become the first drug approved for only one race.
326533
The first study designed just for black patients with heart failure showed that a drug called BiDil reduced their death rate by 43 percent.
259812
The pharmaceutical enlists help to thwart a troublesome illness.
453741
New drugs that are currently in clinical trials for muscle-wasting diseases could become the next big thing for athletes.
218480
In both studies, the drug Avandia, made by GlaxoSmithKline, raised risks of heart failure.
379611
A new drug treatment for a debilitating heart problem affecting millions has been shown to improve survival rates and reduce hospitalizations in black Americans, the first study to discover a beneficial effect for one race.
766518
A study shows promising results for Novartis's COX-2 inhibitor.
545292
Science & environment: Drug that boosts ability to lower cholesterol could help guard against heart attacks, research shows
411818
A drug combination that produced such positive results in clinical trials that they were stopped before their scheduled completion date reduces death from coronary heart disease by up to 43 percent, a new study reports.
447422
A new therapy shows glimpses of promise, but proving a benefit in heart patients could be hard.